Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan

Table 5 Comparison of mean scores of Short Form 36 (SF-36) Health-related Quality of Life (HRQOL) Questionnaire in 26 non-sustained virological responders at different time points of antiviral treatment¹

SF-36 domains/stages	Before treatment	At the 12th wk of treatment	At the end of treatment	At the 6th mo after stopping treatment
General health	54.2±20.2	46.2±16.2b	53.1±19.7	54.1±19.3
Physical functioning	75.0±11.3	59.2±17.8b	68.9±12.7	75.7±8.7
Role-physical	76.9±30.8	51.9±43.0b	77.2±31.9	76.1±31.5
Role-emotional	73.1±37.7	51.3±45.4a	68.1±39.5	65.2±42.0
Social functioning	69.7±14.7	60.1±19.0b	71.7±15.6	69.0±17.6
Body pain	71.5±19.8	55.8±24.4b	67.2±17.1	67.7±24.0
Vitality	52.9±15.9	46.0±17.4a	52.8±18.0	55.0±14.5
Mental health	61.5±13.6	53.5±15.3a	60.5±14.6	61.7±15.3

¹By paired t- test;

^aP<0.05;

^bP<0.01.